Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
Trial details
- Registry ID
- NCT04504942
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Standard-of-care chemotherapy or radiotherapy
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid TumorsNCT04504942 | CytoDyn, Inc. | Phase 2 | Completed | 2021-11-07Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |